Trial Profile
Phase III trial of daily ZP-PTH in patients with osteoporosis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 30 Mar 2015
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 30 Mar 2015 New trial record
- 25 Mar 2015 The company expects to confirm the trial design with regulatory authorities by end of 2015, according to Zosano Pharma media release.